GEMAPHARM LIMITED, Bristol, المملكة المتحدة

المساهمون

الاسم	الحصة	التصويت	منذ

المستفيد الحقيقي النهائي

الاسم	الملكية	البلد	منذ

البيانات المالية

الأرقام الرئيسية من إيداعات الحسابات السنوية.

تحويل إلى

2022

معدل الدوران: £5.4M

الأرقام الرئيسية

معدل الدوران

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2021—

2022£5,368,130

2023—

2024—

الربح / (الخسارة)

2013£52,884

2014£53,169

2015£51,971

2016£62,041

2017—

2018—

2019—

2021—

2022£156,005

2023—

2024—

إجمالي الأصول

2013£54,385

2014£54,670

2015£53,472

2016£63,542

2017£57,052

2018£113,944

2019£138,614

2021£306,264

2022£1,867,580

2023£2,134,881

2024£2,170,325

Net Assets Liabilities

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2021£306,264

2022£1,867,580

2023£2,134,881

2024£2,170,325

Equity

2013—

2014—

2015—

2016—

2017£57,052

2018£113,944

2019£138,614

2021£306,264

2022£1,867,580

2023£2,134,881

2024£2,170,325

Current Assets

2013—

2014£54,670

2015£58,948

2016£64,782

2017£146,383

2018£898,829

2019£1,029,077

2021£2,364,181

2022£4,118,050

2023£6,657,365

2024£4,998,686

Net Current Assets Liabilities

2013—

2014£54,670

2015£53,472

2016£63,542

2017£47,812

2018£104,704

2019£129,374

2021£1,128,186

2022£2,658,340

2023£3,110,641

2024£3,146,085

Total Assets Less Current Liabilities

2013£54,385

2014£54,670

2015£53,472

2016£63,542

2017£57,052

2018£113,944

2019£138,614

2021£1,137,426

2022£2,667,580

2023£3,119,881

2024£3,155,325

Cash Bank On Hand

2013—

2014—

2015—

2016—

2017£112,841

2018£835,829

2019£747,077

2021£1,775,535

2022£2,397,837

2023£2,834,449

2024£2,237,220

Debtors

2013£54,385

2014£54,670

2015£20,512

2016£28,482

2017£33,542

2018£63,000

2019£282,000

2021£588,646

2022£1,720,213

2023£3,822,916

2024£2,761,466

Other Debtors

2013—

2014—

2015—

2016—

2017£5,060

2018£63,000

2019—

2021£252,114

2022—

2023£0

2024£910,821

Creditors

2013—

2014—

2015—

2016—

2017£98,571

2018£794,125

2019£899,703

2021£1,235,995

2022£1,459,710

2023£3,546,724

2024£1,852,601

Trade Creditors Trade Payables

2013—

2014—

2015—

2016—

2017—

2018£0

2019£221,999

2021£702,394

2022£894,601

2023£2,687,936

2024£799,757

Other Creditors

2013—

2014—

2015—

2016—

2017£98,571

2018£783,969

2019£654,348

2021£831,162

2022£800,000

2023£985,000

2024£985,000

Investments Fixed Assets

2013—

2014—

2015—

2016£9,240

2017£9,240

2018£9,240

2019£9,240

2021£9,240

2022£9,240

2023£9,240

2024£9,240

Number Shares Allotted

20131,000

20141,000

20151,000

20161,000

2017—

2018—

2019—

2021—

2022—

2023—

2024—

Par Value Share

2013£1

2014£1

2015£1

2016£1

2017—

2018—

2019—

2021—

2022—

2023—

2024—

Average Number Employees During Period

2013—

2014—

2015—

2016—

20171

2018—

20193

20213

20223

20233

20242

المصاريف الإدارية

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2021—

2022£1,090,474

2023—

2024—

Called Up Share Capital

2013£1,501

2014£1,501

2015£1,501

2016£1,501

2017—

2018—

2019—

2021—

2022—

2023—

2024—

Cash Bank In Hand

2013—

2014£0

2015£38,436

2016£36,300

2017—

2018—

2019—

2021—

2022—

2023—

2024—

Cost Sales

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2021—

2022£4,081,950

2023—

2024—

Creditors Due Within One Year

2013—

2014£0

2015£5,476

2016£1,240

2017—

2018—

2019—

2021—

2022—

2023—

2024—

Gross Profit Loss

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2021—

2022£1,286,180

2023—

2024—

Investments In Associates

2013—

2014—

2015—

2016—

2017£9,240

2018—

2019£9,240

2021£9,240

2022£9,240

2023£9,240

2024£9,240

Other Taxation Social Security Payable

2013—

2014—

2015—

2016—

2017£0

2018£10,156

2019£23,356

2021£283,962

2022£315,470

2023£384,149

2024£444,013

Payments Received On Account

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2021—

2022£0

2023£225,000

2024£359,192

Profit Loss Account Reserve

2013£52,884

2014£53,169

2015£51,971

2016£62,041

2017—

2018—

2019—

2021—

2022—

2023—

2024—

Profit Loss On Ordinary Activities Before Tax

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2021—

2022£195,706

2023—

2024—

Share Capital Allotted Called Up Paid

2013£1,501

2014£1,501

2015£1,501

2016£1,501

2017—

2018—

2019—

2021—

2022—

2023—

2024—

Shareholder Funds

2013£54,385

2014£54,670

2015£53,472

2016£63,542

2017—

2018—

2019—

2021—

2022—

2023—

2024—

Tax Tax Credit On Profit Or Loss On Ordinary Activities

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2021—

2022£39,701

2023—

2024—

Trade Debtors Trade Receivables

2013—

2014—

2015—

2016—

2017£28,482

2018£0

2019£282,000

2021£336,532

2022£1,720,213

2023£3,822,916

2024£1,850,645

Turnover Revenue

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2021—

2022£5,368,130

2023—

2024—

متري	2013	2014	2015	2016	2017	2018	2019	2021	2022	2023	2024
معدل الدوران	—	—	—	—	—	—	—	—	£5,368,130	—	—
الربح / (الخسارة)	£52,884	£53,169	£51,971	£62,041	—	—	—	—	£156,005	—	—
إجمالي الأصول	£54,385	£54,670	£53,472	£63,542	£57,052	£113,944	£138,614	£306,264	£1,867,580	£2,134,881	£2,170,325
Net Assets Liabilities	—	—	—	—	—	—	—	£306,264	£1,867,580	£2,134,881	£2,170,325
Equity	—	—	—	—	£57,052	£113,944	£138,614	£306,264	£1,867,580	£2,134,881	£2,170,325
Current Assets	—	£54,670	£58,948	£64,782	£146,383	£898,829	£1,029,077	£2,364,181	£4,118,050	£6,657,365	£4,998,686
Net Current Assets Liabilities	—	£54,670	£53,472	£63,542	£47,812	£104,704	£129,374	£1,128,186	£2,658,340	£3,110,641	£3,146,085
Total Assets Less Current Liabilities	£54,385	£54,670	£53,472	£63,542	£57,052	£113,944	£138,614	£1,137,426	£2,667,580	£3,119,881	£3,155,325
Cash Bank On Hand	—	—	—	—	£112,841	£835,829	£747,077	£1,775,535	£2,397,837	£2,834,449	£2,237,220
Debtors	£54,385	£54,670	£20,512	£28,482	£33,542	£63,000	£282,000	£588,646	£1,720,213	£3,822,916	£2,761,466
Other Debtors	—	—	—	—	£5,060	£63,000	—	£252,114	—	£0	£910,821
Creditors	—	—	—	—	£98,571	£794,125	£899,703	£1,235,995	£1,459,710	£3,546,724	£1,852,601
Trade Creditors Trade Payables	—	—	—	—	—	£0	£221,999	£702,394	£894,601	£2,687,936	£799,757
Other Creditors	—	—	—	—	£98,571	£783,969	£654,348	£831,162	£800,000	£985,000	£985,000
Investments Fixed Assets	—	—	—	£9,240	£9,240	£9,240	£9,240	£9,240	£9,240	£9,240	£9,240
Number Shares Allotted	1,000	1,000	1,000	1,000	—	—	—	—	—	—	—
Par Value Share	£1	£1	£1	£1	—	—	—	—	—	—	—
Average Number Employees During Period	—	—	—	—	1	—	3	3	3	3	2
المصاريف الإدارية	—	—	—	—	—	—	—	—	£1,090,474	—	—
Called Up Share Capital	£1,501	£1,501	£1,501	£1,501	—	—	—	—	—	—	—
Cash Bank In Hand	—	£0	£38,436	£36,300	—	—	—	—	—	—	—
Cost Sales	—	—	—	—	—	—	—	—	£4,081,950	—	—
Creditors Due Within One Year	—	£0	£5,476	£1,240	—	—	—	—	—	—	—
Gross Profit Loss	—	—	—	—	—	—	—	—	£1,286,180	—	—
Investments In Associates	—	—	—	—	£9,240	—	£9,240	£9,240	£9,240	£9,240	£9,240
Other Taxation Social Security Payable	—	—	—	—	£0	£10,156	£23,356	£283,962	£315,470	£384,149	£444,013
Payments Received On Account	—	—	—	—	—	—	—	—	£0	£225,000	£359,192
Profit Loss Account Reserve	£52,884	£53,169	£51,971	£62,041	—	—	—	—	—	—	—
Profit Loss On Ordinary Activities Before Tax	—	—	—	—	—	—	—	—	£195,706	—	—
Share Capital Allotted Called Up Paid	£1,501	£1,501	£1,501	£1,501	—	—	—	—	—	—	—
Shareholder Funds	£54,385	£54,670	£53,472	£63,542	—	—	—	—	—	—	—
Tax Tax Credit On Profit Or Loss On Ordinary Activities	—	—	—	—	—	—	—	—	£39,701	—	—
Trade Debtors Trade Receivables	—	—	—	—	£28,482	£0	£282,000	£336,532	£1,720,213	£3,822,916	£1,850,645
Turnover Revenue	—	—	—	—	—	—	—	—	£5,368,130	—	—

GEMAPHARM LIMITED

الملخص

القانونية والوضع القانوني

الجدول الزمني (13 الأحداث)

الحسابات السنوية المودعة

الحسابات السنوية المودعة

تأسست الشركة

الشبكة

الملكية والإدارة

Persons with significant control

الجدول الزمني للملكية (6 التغييرات)

استقالة Saville Holdings Ltd (الشركة)

تعيين Saville Holdings Ltd (الشركة)

استقالة Andrew Richard Lamb (شخص)

المساهمون

المستفيد الحقيقي النهائي

الجغرافيا

البيانات المالية

الأرقام الرئيسية

المستندات

تقرير الشركة GEMAPHARM LIMITED

Full accounts (total exemption)

Companexia Document AI

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

تصفح المزيد من الشركات والأشخاص

الصحة المالية

الهوامش

النمو

الكفاءة والعائد

رأس المال العامل والسيولة

الذمم المدينة والدائنة

هيكل رأس المال